Key Highlights

  • MetLife's (MET) Bollinger Band width has compressed to 4.4% of price.
  • About $334.82 million traded versus a typical $287.42 million, but the price barely moved.
  • MetLife authorized a new $3 billion share buyback with its Q2 results.

MetLife (NYSE:MET) was little changed at $97.25 on heavier-than-usual Volume as its Bollinger Band width compressed to 4.4% of price. The life insurer trades just below its 52-week high of $100.93, is up about 20% over the past year and has a fresh $3 billion buyback, setting up a potential breakout above $100.

MetLife's Bollinger Band width has compressed to 4.4 percent of price. Bollinger Bands measure the range a stock trades in around its 20-day average, and when the bands narrow, Volatility is low. A squeeze near a 52-week high often resolves higher, because buyers have been absorbing Supply without pushing the price down.

Recent coverage has focused on MetLife's pre-tax variable Investment income, the returns from Private Equity and similar holdings that can swing quarterly results, and how it ties into full-year guidance. Life insurers are also a direct beneficiary of the rise in Treasury yields, now near 5% for the 10-year, because higher rates lift the income they earn on their huge bond portfolios. MetLife Investment Management recently closed its Galaxy 38 CLO.

MetLife (MET) Draws Heavy Volume on a Flat Day

Heavy trading without a price move suggests large investors are positioning ahead of a breakout. MET closed roughly mid-range for the day. The 52-week range is $67.33 to $100.93, and the stock sits within about 4% of its high.

MET Technical Levels: Strong Structure, Cooling Momentum

MetLife trades above its moving averages, which keeps the broader uptrend intact. Moving averages show the prevailing trend, and staying above them means buyers still control the bigger picture.

MACD sits below its signal line. MACD tracks momentum, and a reading below the signal line shows the short-term pace has slowed, which is typical during a squeeze.

The key level is the 52-week high of $100.93. A close above it would confirm a breakout to new highs, while the moving averages below act as support.

Valuation and Dividend

MetLife pays $2.37 a year, a yield of about 2.4%, and has raised its Dividend for 13 consecutive years. Analysts rate MET a Buy, with an average target near $105.06, about 8% above the current price. The next Earnings report is expected around Nov. 4.